With the ongoing energy crisis, Rebekah Jordan considers the effect of surging manufacturing costs on the pharma sector in Europe, and pharma's hopes to mitigate production and supply chain issues with resiliency and innovation.
It’s been a long winter – and an expensive one for a lot of us. The European energy crisis remains a pressing concern, for both the industrial sector and on a personal scale.